Prevalence of Hepatitis B, C, HIV and syphilis markers among refugees in Bari, Italy

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Tafuri, Silvio ^a,b   Prato, Rosa ^b,c   Martinelli, Domenico ^b,c   Melpignano, Livio ^a,b   De Palma, Maria ^a,b   Quarto, Michele ^a,b   Germinario, Cinzia ^a,b  

^a UNIVERSITY OF BARI   (Italy)

^b NONE   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS ANTIBODY; CARDIOLIPIN; CHOLESTEROL; HEPATITIS B ANTIBODY; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; PHOSPHATIDYLCHOLINE; VENEREAL DISEASE RESEARCH LABORATORY ANTIGEN;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; MAJOR CLINICAL STUDY; MALE; REFUGEE; SCHOOL CHILD; SCREENING TEST; SEROLOGY; SEX DIFFERENCE; SYPHILIS; VENEREAL DISEASE REACTION TEST; VIRUS DETECTION; BLOOD; EPIDEMIOLOGY; IMMUNOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; CARDIOLIPINS; CHILD; CHOLESTEROL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; ITALY; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINES; REFUGEES; SEROEPIDEMIOLOGIC STUDIES; SYPHILIS; YOUNG ADULT;

EID: 77954666829     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-213     Document Type: Article

References (22)

1. Caritas Migrantes Immigrazione Dossier Statistico 2008 XVIII rapporto. Edizioni Idos Roma. 2008, Caritas Migrantes.
2. Da Molin G, . (a cura di) L'immigrazione albanese in Puglia Saggi interdisciplinari Cacucci editore. Bari. 1999, (a cura di).
3. Decreto Legislativo 28 gennaio 2008, n. 25. Attuazione della direttiva 2008/85/CE recane norme minime per le procedure applicate negli stati membri ai fini del riconoscimento e della revoca dello status di rifugiato Pubblicato nella Gazzetta Ufficiale n. 40 del 16 febbraio 2008.
4. Division of Global Migration and Quarantine Technical instruction for medical examination of aliens. Atlanta: National Center for Infectious Disease, Center for Disease Control and Prevention, June 1991 with charges July 1992, Division of Global Migration and Quarantine., http://www.cdc.gov/quarantine/index.html
5. Minnesota Department of Health Health assessment screening for Minnesota refugees. 1999, 27:41-2. Disease Control News-letter, Minnesota Department of Health.
6. Ackerman LK. Health problems of refugees. J Am Board Fam Pract 1997, 10(5):337-48.
7. Walker PF, Jaranson J. Refugee and immigrant health care. Med Clin North Am 1999, 83(4):1103-20.
8. Mabey D, Mayaud P. Sexually transmitted diseases in mobile populations. Genitourin Med 1997, 73(1):18-22. 1195754, 9155550.
9. Del Amo J, Bröring G, Hamers FF, Infuso A, Fenton K. Monitoring HIV/AIDS in Europe's migrant communities and ethnic minorities. AIDS 2004, 18(14):1867-73. 10.1097/00002030-200409240-00002, 15353972.
10. Gaeta GB, Cuomo G. Epidemiologia delle epatiti virali in Italia. LigandAssay 2006, 11(4).
11. Ministero della Salute 2009, 22-24. Ministero della Salute., http://www.ministerosalute.it/hiv/paginaInternaHiv.jsp?id=198&menu=strumentieservizi
12. MacPherson DW, Gushulak AD. Syphilis in Immigrants and the Canadian Immigration Medical Examination. J Immigrant Minority Health 2008, 10:1-6.
13. Majori S, Baldo V, Tommasi I, Malizia M, Floreani A, Monteiro G, et al. Hepatitis A, B, and C infection in a Community of Sub Saharan Immigrants Living in Verona (Italy). Journal of Travel Medicine 2008, 15(5):323-327. 10.1111/j.1708-8305.2008.00230.x, 19006505.
14. Vasilopoulou VA, Hadjichristodoulou C. Migration and viral hepatitis. Viral Hepatitis 2008, 16:18-19.
15. Palumbo E, Scotto G, Faleo G, Ribelli DC, Saracino A, Angarano G. Prevalence of HBV-genotypes in immigrants affected by HBV-related chronic active hepatitis. Arq. Gastroenerol, Sao Paulo 2007, 44(n. 1).
16. van der Veen YJ, de Zwart O, Voeten HA, Mackenbach JP, Richardus JH. Hepatitis B screening in the Turkish-Dutch population in Rotterdam, the Netherlands; qualitative assessment of socio-cultural determinants. BMC Public Health 2009, 9:328. 10.1186/1471-2458-9-328, 2754456, 19740421.
17. Shiell A, La MG. The cost of hepatitis C and the cost-effectiveness of its prevention. Health Policy 2001, 58(2):121-131. 10.1016/S0168-8510(01)00159-2, 11551662.
18. Castelnuovo E, Thompson-Coon J, Pitt M, Cramp M, Siebert U, Price A, et al. The cost-effectiveness of testing for hepatitis C in former injecting drug users. Health Technol Assess 2006, 10(32):1-93.
19. Camoni L, Salfa MC, Regine V, Pasqualini C, Borghi V, Icardi G, et al. HIV incidence estimate among non-nationals in Italy. Eur J Epidemiol 2007, 22:813-817. 10.1007/s10654-007-9185-3, 17902027.
20. Thelot FL, . HIV/AIDS in South Africa and Haiti the failure of epidemic governance and achievement of the MDGs. Sante 2009, 19(3):121-32. HIV/AIDS in South Africa and Haiti.
21. Gonzalez M, Piccinina V, Regine V, Catalano L, Hassan HJ. Sorveglianza delle donazioni di sangue in Italia nell'anno 2000. NotIstSuperSanità 2003, 16(3):2-6.
22. Wiwanitkit V. when to re-test? Southeast Asian J Trop Med Public Health. Biological false reactive VDRL tests 2002, 33(Suppl 3):131-2.